GNRH1 and posterior cortical atrophy: Specifically, we demonstrated that GnRH agonists, significantly and dose-dependently, reduce the proliferation of both androgen-dependent (LNCaP) and castration-resistant (PC3, DU145) human PCa cells, both in vitro and in vivo [21,22,23,139,155,169,170].